Side effects of clarinex desloratadine

Buy cheap Desloratadine

Considered to mediate primarily the physiological and behavioural effects of dopamine and dopamine-receptor agonists for review, see ref. 13 ; . In vivo studies revealed that D2 autoreceptors are more sensitive to stimulation by dopamine-receptor agonists than their postsynaptic counterparts for reviews, see ref. 75-77 ; . This differential responsiveness was explained in several ways. Carlsson and co-workers launched the hypothesis that these two types of D2 receptors do not represent two distinct forms of the D2 receptor but are derived from a homogenous population of D2 receptors existing in different states of adaptation as a result of variations in previous dopamine-receptor agonist dopamine ; occupancy [78-801. According to this hypothesis, the higher sensitivity of D2 autoreceptors than of postsynaptic D2 receptors to stimulation by dopamine-receptor agonists under physiological conditions results from a lower endogenous tone of dopamine at D2 autoreceptors than at postsynaptic D2 receptors. This is assumed to be caused by the localization of D2 autoreceptors largerly or entirely outside the synaptic cleft, whereas postsynaptic D2 receptors are located inside the synaptic cleft. Another hypothesis, put forward by Meller and colleagues, clarifies the difference in sensitivity of D2 autoreceptors and postsynaptic D2 receptors by the presence or absence of receptor reserve [81-841. According to this hypothesis, the higher sensitivity of D2 autoreceptors with respect to postsynaptic D2 receptors results from the presence of a higher percentage of spare receptors, i.e. a more efficient receptor-effector coupling presynaptically than postsynaptically. This preferential activation of D2 autoreceptors by dopamine-receptor agonists formed a strong incentive for many research groups to attempt to develop selective D2autoreceptor agonists. Mzlbition of dopamine neurotransmission by selective activation of D2 autoreceptors seemed to hold the promise of an elegant way in treating schizophrenia, a neuropsychiatric disorder thought to involve an increased dopamine activity in the CNS, without evoking extrapyramidal side effects [85]. In recent years, various agents were introduced which allegedly displayed a selective agonist profile at dopamine autoreceptors see 1.3.2 ; . On first impression, this would suggest a pharmacological distinction between D2 autoreceptors and postsynaptic D2 receptors. However, Drukarch and Stoof showed, in their recent review about the existence of selective agents for D2 autoreceptors, that D2 autoreceptors and postsynaptic D2 receptors display similar pharmacological characteristics [77].Based on these findings they concluded that D2 autoreceptors and postsynaptic D2 receptors are similar if not identical entities. A sound strategy to preferentially inhibit the activity of dopamine neurons would be the development of D2-receptor agonists with a partial agonist profile [86]. The most favourable D2-receptor partial agonists would act presynaptically almost as full agonists and postsynaptically as partial agonists with very low intrinsic efficacy. This last property is needed to avoid the negative effects of antagonism at postsynaptic D2 receptors. According to the hypothesis of Carlsson and co-workers, the intrinsic efficacy of such D2-receptor partial agonists would be at maximum at those D2 receptors, where the endogenous dopamine occupancy is at minimum [87]. Thus, not!